Modulation of autophagy for the treatment of liver diseases.

Modulation of autophagy for the treatment of liver diseases.

Item
http://www.wikidata.org/entity/Q38205866
Autophagy: a new target for nonalcoholic fatty liver disease therapyEpigallocatechin-3-gallate opposes HBV-induced incomplete autophagy by enhancing lysosomal acidification, which is unfavorable for HBV replicationTraditional Chinese herbal extracts inducing autophagy as a novel approach in therapy of nonalcoholic fatty liver diseaseAkebia Saponin D Decreases Hepatic Steatosis through Autophagy Modulation.Early to Phase II drugs currently under investigation for the treatment of liver fibrosis.Reactive Oxygen Species-Mediated c-Jun NH2-Terminal Kinase Activation Contributes to Hepatitis B Virus X Protein-Induced Autophagy via Regulation of the Beclin-1/Bcl-2 Interaction.Relevance of autophagy to fatty liver diseases and potential therapeutic applications.Celecoxib alleviates nonalcoholic fatty liver disease by restoring autophagic flux.Autophagy and Akt in the protective effect of erythropoietin helix B surface peptide against hepatic ischaemia/reperfusion injury in mice
P2860

Modulation of autophagy for the treatment of liver diseases.

Item
http://www.wikidata.org/entity/Q38205866
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Modulation of autophagy for the treatment of liver diseases.
@en
type
label
Modulation of autophagy for the treatment of liver diseases.
@en
prefLabel
Modulation of autophagy for the treatment of liver diseases.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P356
P1433
P1476
Modulation of autophagy for the treatment of liver diseases
@en
P2093
P2860
P304
P31
P356
10.1517/13543784.2014.912274
P407
P433
P478
P50
P577
P5875
P698
P921